4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001280044-26-000004
Director acquired 11,580 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
GOWEN MAXINE · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-05 | Exercise or conversion : show line 1 in the form | +11,580 | 33,334 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-04 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +42,350 | 42,350 | D |
| 2026-06-04 | Grant or award : show line 3 in the form Restricted Stock Units | +10,987 | 10,987 | D |
| 2026-06-05 | Exercise or conversion : show line 4 in the form Restricted Stock Units | −11,580 | 0 | D |
Loading xslF345X06/form4-06082026_040601.xml…